Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

Javid Gaziev, Antonella Isgro, MD, Katia Paciaroni, MD, Marco Marziali, MD, Gioia De Angelis, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD

Blood (2018) 132 (Supplement 1): 5777.

https://doi.org/10.1182/blood-2018-99-109764

Published: 2018

Journal Articles

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Javid Gaziev, Antonella Isgrò, MD, Pietro Sodani, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Marco Marziali, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD, Tiziana Gallucci, PhD, Guido Lucarelli, MD

Blood (2017) 130 (Supplement 1): 663.

https://doi.org/10.1182/blood.V130.Suppl_1.663.663

Published: 2017

Journal Articles

Evaluation of the Impact of Anti-Thymocyte Globulin on Post-Transplant Outcomes in Sickle Cell Anemia Patients Undergoing BMT from HLA-Identical Sibling Donors

Javid Gaziev, MD, Antonella Isgro, MD, Marco Marziali, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Marco Andreani, PhD, Cecilia Alfieri, MD, Michela Ribersani, MD, Guido Lucarelli, MD

Blood (2016) 128 (22): 3468.

https://doi.org/10.1182/blood.V128.22.3468.3468

Published: 2016

Journal Articles

Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft

Javid Gaziev, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Antonella Isgro, MD, Marco Marziali, MD, Marco Andreani, PhD, Cecilia Alfieri, MD, Michela Ribersani, MD, Guido Lucarelli, MD

Blood (2016) 128 (22): 2289.

https://doi.org/10.1182/blood.V128.22.2289.2289

Published: 2016

Journal Articles

Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

Javid Gaziev, MD, Gioia De Angelis, MD, Antonella Isgro, MD, Pietro Sodani, MD, Marco Marziali, MD, Katia Paciaroni, MD, Marco Andreani, PhD, Manuela Testi, PhD, Cristiano Gallucci, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Maria Troiano, PhD, Aldo Morrone, MD, Guido Lucarelli, MD

Blood (2015) 126 (23): 620.

https://doi.org/10.1182/blood.V126.23.620.620

Published: 2015

Journal Articles

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Antonella Isgro, MD, Javid Gaziev, Pietro Sodani, MD, Marco Andreani, PhD, Manuela Testi, PhD, Katia Paciaroni, MD, Cristiano Gallucci, MD, Gioia De Angelis, MD, Marco Marziali, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Olufemi O Akinyanju, T. Thompson Wakama, Festus Olusola Olowoselu, Guido Lucarelli, MD

Blood (2015) 126 (23): 4598.

https://doi.org/10.1182/blood.V126.23.4598.4598

Published: 2015

Journal Articles

Outcome Of Bone Marrow Transplantation In Lebanese Children With β-Thalassemia Major

Adlette Inati, MD, Javid Gaziev, MD, Hussein A Abbas, PhD, Serge Korjian, BSc, Yazan Daaboul, BSc, Mario Kahale, MD, Katia Paciaroni, MD, Gioia de Angelis, MD, Ali T Taher, MD, Therese Abi Nasr, MD, Suzan Koussa, MD, Guido Lucarelli, MD

Blood (2013) 122 (21): 5505.

https://doi.org/10.1182/blood.V122.21.5505.5505

Published: 2013

Journal Articles

High Engraftment Rate after Second Stem Cell Transplantation for Thalassemia: A Prospective Study.

Javid Gaziev, MD, Guido Lucarelli, MD, Pietro Sodani, MD, Paola Polchi, MD, Katia Paciaroni, MD, Marco Marziali, MD, Antonella Isgro, MD, Cecilia Alfieri, MD, Maria Domenica Simone, MD, Andrea Roveda, MD, Aldo Montuoro, MD, Gioia De Angelis, MD, Cristiano Gallucci

Blood (2007) 110 (11): 1107.

https://doi.org/10.1182/blood.V110.11.1107.1107

Published: 2007

Journal Articles

Rituximab in Refractory Idiopathic Thrombocytopenic Purpura (ITP).

Cristina Santoro, MD, Francesca Biondo, MD, Gioia De Angelis, MD, Mariastefania De Propris, BD, Annalisa De Vellis, MD, Anna Guarini, BD, Luigi Malandruccolo, MD, Angela Rago, MD, Robert Foa, MD, Mariagabriella Mazzucconi, MD

Blood (2006) 108 (11): 3979.

https://doi.org/10.1182/blood.V108.11.3979.3979

Published: 2006

NARROW

Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Evaluation of the Impact of Anti-Thymocyte Globulin on Post-Transplant Outcomes in Sickle Cell Anemia Patients Undergoing BMT from HLA-Identical Sibling Donors

Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft

Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Outcome Of Bone Marrow Transplantation In Lebanese Children With β-Thalassemia Major

High Engraftment Rate after Second Stem Cell Transplantation for Thalassemia: A Prospective Study.

Rituximab in Refractory Idiopathic Thrombocytopenic Purpura (ITP).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only